USFDA successfully concludes inspection at Piramal Pharma USA facility
Mumbai: Piramal Pharma Limited has informed through a recent BSE filing that the US Food and Drug ADministration (US FDA) has issued an Establishment Inspection Report (EIR) for the Riverview, USA manufacturing facility and the inspection has now been successfully closed by the US FDA. Medical Dialogues team had earlier reported that the US FDA had concluded a Pre-Approval […]